Calvert US Mid-Cap Core Responsible Index ETF (CVMC) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CVMC Stock Alerts $54.91 +0.24 (+0.44%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Calvert US Mid-Cap Core Responsible Index ETF Stock Price Performance5 Day Performance+0.16%1 Month Performance-5.13%3 Month Performance+3.47%6 Month Performance+24.32%Year-To-Date Performance+2.76%1 Year Performance+13.80% Receive CVMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Calvert US Mid-Cap Core Responsible Index ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CVMC Stock Chart for Sunday, April, 28, 2024 CVMC Chart by TradingView Calvert US Mid-Cap Core Responsible Index ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$54.66$54.91+0.46%$54.91$54.9153 shs$52.16 million04/25/2024$54.85$54.66-0.35%$54.66$54.66301 shs$51.93 million04/24/2024$54.82$54.85+0.05%$54.85$54.711,571 shs$52.11 million04/23/2024$54.12$54.82+1.29%$54.82$54.8245 shs$52.08 million04/22/2024$53.67$54.12+0.84%$54.12$54.12226 shs$51.41 million04/19/2024$53.73$53.67-0.11%$53.70$53.59424 shs$50.99 million Get the Latest News and Ratings for CVMC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calvert US Mid-Cap Core Responsible Index ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$53.87$53.73-0.26%$53.73$53.73232 shs$51.04 million04/17/2024$54.17$53.87-0.55%$53.87$53.871,542 shs$24.24 million04/16/2024$54.42$54.17-0.46%$54.17$53.871,542 shs$24.38 million04/15/2024$55.03$54.42-1.11%$55.14$54.422,132 shs$24.49 million04/12/2024$56.04$55.03-1.79%$55.03$55.00706 shs$24.77 million04/11/2024$56.00$56.04+0.07%$56.04$56.04256 shs$25.22 million04/10/2024$56.91$56.00-1.61%$56.05$55.821,119 shs$25.20 million04/09/2024$56.78$56.91+0.23%$56.91$56.77312 shs$25.61 million04/08/2024$56.60$56.78+0.31%$56.84$56.78560 shs$25.55 million04/05/2024$56.17$56.60+0.77%$56.62$56.55578 shs$25.47 million04/04/2024$56.78$56.17-1.07%$56.19$56.17238 shs$25.28 million04/03/2024$56.67$56.78+0.19%$56.78$56.78216 shs$25.55 million04/02/2024$57.42$56.67-1.31%$56.67$56.5727,017 shs$25.50 million04/01/2024$57.88$57.42-0.79%$57.42$57.402,605 shs$25.84 million03/29/2024$57.88$57.88-0.01%$57.88$57.802,022 shs$26.04 million03/28/2024$57.60$57.88+0.49%$57.88$57.802,022 shs$26.05 million03/27/2024$56.86$57.60+1.30%$57.60$57.281,373 shs$25.92 million03/26/2024$56.81$56.86+0.09%$57.07$56.86365 shs$25.59 million03/25/2024$56.91$56.81-0.17%$56.90$56.811,092 shs$25.56 million03/22/2024$57.30$56.91-0.68%$56.97$56.91719 shs$25.61 million03/21/2024$56.71$57.30+1.04%$57.30$57.282,481 shs$25.79 million03/20/2024$56.12$56.71+1.05%$56.71$56.161,496 shs$25.52 million03/19/2024$55.79$56.12+0.59%$56.12$56.054,383 shs$25.25 million03/18/2024$55.85$55.79-0.10%$56.00$55.79349 shs$25.11 million03/15/2024$55.88$55.85-0.05%$55.95$55.852,611 shs$25.13 million03/14/2024$56.60$55.88-1.27%$55.98$55.88144 shs$25.15 million03/13/2024$56.65$56.60-0.09%$56.78$56.572,259 shs$25.47 million03/12/2024$56.41$56.65+0.43%$56.65$56.55733 shs$25.49 million03/11/2024$56.57$56.41-0.28%$56.46$56.391,105 shs$25.38 million03/08/2024$56.80$56.58-0.39%$56.72$56.58607 shs$25.46 million03/07/2024$56.23$56.80+1.02%$56.80$56.80245 shs$25.56 million03/06/2024$55.87$56.23+0.64%$56.23$56.22433 shs$25.30 million03/05/2024$56.24$55.87-0.65%$55.87$55.6594,578 shs$25.14 million03/04/2024$56.05$56.24+0.34%$56.24$56.24214 shs$25.31 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$55.73$56.05+0.57%$56.05$55.69815 shs$25.22 million02/29/2024$55.32$55.73+0.75%$55.73$55.572,909 shs$25.08 million02/28/2024$55.31$55.32+0.02%$55.33$55.32366 shs$24.89 million02/27/2024$55.04$55.31+0.49%$55.31$55.31116 shs$24.89 million02/26/2024$55.07$55.04-0.06%$55.17$55.042,136 shs$24.77 million02/23/2024$54.88$55.07+0.35%$55.07$54.90423 shs$24.78 million02/22/2024$54.12$54.88+1.40%$54.88$54.8845 shs$24.70 million02/21/2024$54.19$54.12-0.13%$54.12$53.95726 shs$24.35 million02/20/2024$54.55$54.19-0.66%$54.31$54.182,843 shs$24.39 million02/19/2024$54.55$54.55+0.00%$54.86$54.55300 shs$24.55 million02/16/2024$54.89$54.55-0.62%$54.86$54.55324 shs$24.55 million02/15/2024$54.24$54.89+1.20%$54.89$54.85284 shs$24.70 million02/14/2024$53.33$54.24+1.71%$54.29$54.24878 shs$24.41 million02/13/2024$54.54$53.33-2.22%$53.41$53.06765 shs$24.00 million02/12/2024$54.17$54.54+0.68%$54.75$54.37905 shs$24.54 million02/09/2024$53.87$54.17+0.56%$54.19$53.941,280 shs$24.38 million02/08/2024$53.49$53.87+0.71%$53.88$53.741,956 shs$24.24 million02/07/2024$53.28$53.49+0.39%$53.66$53.27619 shs$24.07 million02/06/2024$53.00$53.28+0.53%$53.28$53.27343 shs$23.98 million02/05/2024$53.53$53.00-0.99%$53.04$52.67653 shs$23.85 million02/02/2024$53.28$53.53+0.47%$53.53$53.31955 shs$24.09 million02/01/2024$52.70$53.28+1.10%$53.28$52.72465 shs$23.98 million01/31/2024$53.59$52.70-1.66%$53.40$52.70849 shs$23.72 million01/30/2024$53.59$53.590.00%$53.63$53.55513 shs$24.12 million01/29/2024$53.07$53.59+0.99%$53.59$53.3226,853 shs$24.12 million Related Companies: Argent Mid Cap ETF Stock Chart Pacer Lunt MidCap Multi-Factor Alternator ETF Stock Chart American Century Mid Cap Growth Impact Stock Chart Direxion Daily Mid Cap Bull 3X Shares Stock Chart ProShares UltraPro MidCap400 Stock Chart Alger Mid Cap 40 ETF Stock Chart SoFi Next 500 ETF Stock Chart Avantis U.S. Mid Cap Value ETF Stock Chart Mid Cap US Equity Select ETF Stock Chart Avantis U.S. Mid Cap Equity ETF Stock Chart Receive CVMC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Calvert US Mid-Cap Core Responsible Index ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:CVMC) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calvert US Mid-Cap Core Responsible Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.